The role of corticotropin-releasing factor in drug addiction.
about
Natural rewards, neuroplasticity, and non-drug addictionsStress, dysregulation of drug reward pathways, and the transition to drug dependenceNeurotensin receptor antagonist administered during cocaine withdrawal decreases locomotor sensitization and conditioned place preferenceThe neurobiology and genetics of impulse control disorders: relationships to drug addictionsPharmacotherapy of methamphetamine addiction: an updateDopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex.The Addictive Model of Self-Harming (Non-suicidal and Suicidal) BehaviorFischer 344 and Lewis Rat Strains as a Model of Genetic Vulnerability to Drug AddictionMass spectrometry for the detection of potential psychiatric biomarkersDrug withdrawal conceptualized as a stressor.Stress and VTA synapses: implications for addiction and depressionEndocannabinoid regulation of acute and protracted nicotine withdrawal: effect of FAAH inhibitionAn Update on CRF Mechanisms Underlying Alcohol Use Disorders and DependenceCorticotropin releasing factor-induced CREB activation in striatal neurons occurs via a novel Gβγ signaling pathwayDopamine receptor mechanisms mediate corticotropin-releasing factor-induced long-term potentiation in the rat amygdala following cocaine withdrawalAdolescent alcohol exposure alters the central brain circuits known to regulate the stress responseChronic amphetamine treatment enhances corticotropin-releasing factor-induced serotonin release in the amygdalaMethamphetamine causes differential alterations in gene expression and patterns of histone acetylation/hypoacetylation in the rat nucleus accumbensTopographical distribution of corticotropin-releasing factor type 2 receptor-like immunoreactivity in the rat dorsal raphe nucleus: co-localization with tryptophan hydroxylaseHow to study sex differences in addiction using animal models.Stress-Induced Reinstatement of Drug Seeking: 20 Years of Progress.Polymorphism in the corticotropin-releasing factor receptor 1 (CRF1-R) gene plays a role in shaping the high anxious phenotype of Marchigian Sardinian alcohol-preferring (msP) rats.Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinenceTherapeutic utility of non-peptidic CRF1 receptor antagonists in anxiety, depression, and stress-related disorders: evidence from animal modelsAdrenal activity during repeated long-access cocaine self-administration is required for later CRF-Induced and CRF-dependent stressor-induced reinstatement in rats.The corticotropin-releasing factor receptor-1 pathway mediates the negative affective states of opiate withdrawal.The role of CRF and CRF-related peptides in the dark side of addiction.The bed nucleus is a neuroanatomical substrate for the anorectic effect of corticotropin-releasing factor and for its reversal by nociceptin/orphanin FQ.Dopamine enhances fast excitatory synaptic transmission in the extended amygdala by a CRF-R1-dependent process.Urocortin 1 microinjection into the mouse lateral septum regulates the acquisition and expression of alcohol consumptionVTA CRF neurons mediate the aversive effects of nicotine withdrawal and promote intake escalation.Parvalbumin Interneurons of Central Amygdala Regulate the Negative Affective States and the Expression of Corticotrophin-Releasing Hormone During Morphine Withdrawal.Defining the role of corticotropin releasing factor binding protein in alcohol consumption.Social stress and CRF-dopamine interactions in the VTA: role in long-term escalation of cocaine self-administrationNeurobiological mechanisms of addiction: focus on corticotropin-releasing factor.Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin.Stress-induced potentiation of cocaine reward: a role for CRF R1 and CREB.From molecule to market: steroid hormones and financial risk-taking.The effects of opioids and opioid analogs on animal and human endocrine systemsSocial stimuli enhance phencyclidine (PCP) self-administration in rhesus monkeys.
P2860
Q22251254-C779E031-DE1E-44ED-855C-C7923F10E026Q24629577-1799B182-E076-4DAA-A2B4-B60D99630541Q24634249-0EA83B8E-9935-4071-83F0-9D4225DD1BDDQ24642641-8E4066A1-2B6F-4F29-8A81-212794B7A09AQ24648913-AAD218B9-C863-44E3-8413-0556426ACD61Q24681363-1D8A920D-2E2C-46EA-B400-9BD1C1FB9273Q26766469-F35823C5-5816-4E90-9BDB-7F6EBDA8EA57Q26768236-274B24B0-A0A6-4DE8-A87E-4157D87383E5Q26852637-BA68B296-5BAC-4BC0-BA0F-DFD1F110C6C7Q26997989-FD2F5686-DAB4-40F3-828F-8A87D9FDDD49Q26999218-EF82F56E-F9EA-4F9F-A685-F9D7D7055C26Q27311588-62F4C61E-F73D-45FB-AB16-87CDE39342BDQ28069782-F834F685-D697-4C02-95F6-33A2CE607555Q28477480-16DE49FD-F45E-4EC8-8D51-C9706A5AAFADQ28566489-C7027E35-23D5-496E-AF6D-69BD712806A7Q28567870-CB314FAA-7AEC-4C27-AF3F-693D8D157DDBQ28568006-1B2FA68D-9D57-4C7B-96A5-FF871F66D599Q28568475-BD6F8084-F9CB-48C5-BA12-AAD4B9B220B7Q28569531-4793D761-8572-4FDB-A788-BF2BB0E53304Q30276500-1DF54314-69F5-4513-A2EF-8AF54B99C0B5Q30366964-D46A0F3B-02F4-457C-A2EC-A2FACE1587C5Q30389951-C29E962B-33D8-4439-BD59-3A9A9905FE3AQ30455336-C7FFEE1B-9A15-46E8-8968-72BA582C0756Q30466695-55D31CE9-BC5B-4483-B0B2-D5A9D1D9FD98Q30467194-96E0F873-A3F6-446D-8F68-B174E05E6F67Q30476553-F4F580DA-C221-4FFB-B536-6014B0AE43F1Q30476985-C80CE839-FE4B-4EE6-8B44-5D845C61693FQ30477084-7BF77529-0517-40BC-BEAB-232C2A929BB2Q30488917-65BAE8A8-6FD9-4968-904C-AF75F8F894C9Q30491437-5E091629-913B-430C-94CB-27B7D5C191A8Q30601106-CDEC2B1D-8954-4F4B-AD3B-0F6298BCC8B4Q30830791-8C6BB271-BDD0-417C-9CF5-2C2CE4AC51AEQ30838960-FB17DD57-4307-46DA-B28E-AA1F581E4D6FQ33575214-8D83E9C1-0B94-4495-BB2D-EA84E336A680Q33616639-1D29F464-4FCF-4DE7-9E0C-DE15905A3D50Q33643476-853273C1-1956-4C1D-8469-B99204B2EB01Q33665169-1B130358-78C1-484A-92BC-755ED62D89B1Q33683413-0D80E418-9086-493A-86CC-C6099F85D85EQ33779667-6917DC6D-6CA1-4BDA-A9CF-C9D49573849BQ33796504-71A5D091-31BE-4934-AAD6-F008BC98550E
P2860
The role of corticotropin-releasing factor in drug addiction.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The role of corticotropin-releasing factor in drug addiction.
@ast
The role of corticotropin-releasing factor in drug addiction.
@en
The role of corticotropin-releasing factor in drug addiction.
@nl
type
label
The role of corticotropin-releasing factor in drug addiction.
@ast
The role of corticotropin-releasing factor in drug addiction.
@en
The role of corticotropin-releasing factor in drug addiction.
@nl
prefLabel
The role of corticotropin-releasing factor in drug addiction.
@ast
The role of corticotropin-releasing factor in drug addiction.
@en
The role of corticotropin-releasing factor in drug addiction.
@nl
P2093
P1476
The role of corticotropin-releasing factor in drug addiction
@en
P2093
P304
P577
2001-06-01T00:00:00Z